NDC 51754-6013 – Glyrx-pf
Glycopyrrolate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC51754-6013
Product details
- Brand name
- Glyrx-pf
- Generic name
- Glycopyrrolate
- Labeler
- Exela Pharma Sciences, LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- NDA · NDA210997
- Marketed since
- June 1, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Glycopyrrolate .2 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51754-6013-3 | 10 SYRINGE, PLASTIC in 1 CARTON (51754-6013-3) / 3 mL in 1 SYRINGE, PLASTIC | Dec 15, 2020 |
Other Glyrx-pf products
- 51754-6000 Glycopyrrolate .2 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC
- 51754-6001 Glycopyrrolate .2 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC
- 51754-6015 Glycopyrrolate .2 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC